Different interventions that range from identification of patients and maintenance of their records during clinical trials, to application in drug discovery and repurposing are gradually incorporating artificial intelligence, thereby revolutionizing drug discovery and development setting.
Artificial Intelligence in Medicine Market is anticipated to reach $18.12 billion by 2025, registering a CAGR of 49.6% during the forecast period.
The growth of global artificial intelligence (NYSE:AI) in medicine market is driven by the surge in AI capabilities due to an increase in processing power, the need to compensate for the lack of skilled professionals in healthcare, and growing awareness regarding the importance of personalized medicine. However, limitations of AI in critical decision making and slow acceptance of AI by healthcare professionals impede the market growth. Nonetheless, the increase in adoption of AI technology in developing countries would provide lucrative opportunities for emerging market players in the near future.
Request Report Sample at: https://www.alliedmarketresearch.com/request-sample/4749
Industry Key Players
The key players analyzed in the report include
· Welltok Inc.
· Intel Corporation
· Nvidia Corporation
· Google Inc.
· IBM Corporation
· Microsoft Corporation
· General Vision Inc.
· Enlitic Inc.
· BioXcel Corporation
· Berg Health
Based on product type, the software segment dominated the global market in 2017 on account of perpetual software innovation that feeds the requirement of the healthcare sector. However, in the forecast period, the hardware segment is expected to witness the fastest growth. Based on technology, the natural language processing segment generated the highest revenue in 2017 and is expected to continue dominance through 2025. However, the deep learning segment is projected to grow at the fastest rate, as it enhances integral components of AI protocols like signal reduction, data mining, and image recognition.
Based on application, the personalized medicine segment is anticipated to encounter the fastest growth rate during the forecast period. By region, North America occupied the largest share in 2017 due to the easy availability of capital investment for implementing AI in drug discovery and the rise in adoption of AI technology by biotechnology and pharmaceutical companies. However, Asia-Pacific is projected to grow at the fastest CAGR of 55.0% from 2018 to 2025, due to growth in healthcare expenditure and rise in the R&D activities for advancement in AI technology.
About the author:
WiredRelease
WiredRelease is designed to provide the best and most penetrating research required to all commercial, industrial and profit-making ventures in any sector of online business.